|
TORONTO (AP) - India's largest drug company announced Thursday it was entering the Canadian generic drug market with the launch of a subsidiary called Ranbaxy Pharmaceuticals Canada Inc.
Ranbaxy Laboratories Ltd. said the firm already had regulatory approval to sell eight products and four others were awaiting approval.
"We are a major player on the global stage," Dr. Brian Tempest, CEO and managing director of Ranbaxy Laboratories, said in a telephone interview. "Whenever we've entered markets around the world, we've been seen as an element of change that has brought into those markets some generic products faster than they may otherwise have risen."
|